NCT01980966View on ClinicalTrials.gov

A Study of MHAA4549A in Healthy Volunteers in an Influenza Challenge Model

PHASE2CompletedINTERVENTIONAL

Enrollment

101

Participants

Timeline

Start Date

November 25, 2013

Primary Completion Date

June 19, 2014

Study Completion Date

June 19, 2014

Conditions

Healthy Volunteer

Interventions

DRUG

MHAA549A

IV dose

DRUG

Placebo

IV dose

DRUG

oseltamivir [Tamiflu]

Orally b.i.d, 5 days

Trial Locations (1)

NW1 0NH

Retroscreen Ltd, London

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY